New: Evolving the Heatmap: Dow Jones, Nasdaq 100, Russell 2000, and More

Learn More
Last Close
Sep 17  •  04:00PM ET
4.91
Dollar change
-0.55
Percentage change
-10.07
%
Index- P/E- EPS (ttm)-19.05 Insider Own0.34% Shs Outstand1.42M Perf Week1.66%
Market Cap6.97M Forward P/E- EPS next Y-0.74 Insider Trans0.00% Shs Float1.41M Perf Month-49.69%
Enterprise Value5.78M PEG- EPS next Q-0.82 Inst Own1.17% Short Float1.58% Perf Quarter-21.44%
Income-10.50M P/S- EPS this Y60.16% Inst Trans25.69% Short Ratio0.03 Perf Half Y-11.15%
Sales0.00M P/B- EPS next Y89.85% ROA-165.62% Short Interest0.02M Perf YTD-22.80%
Book/sh-2.00 P/C3.37 EPS next 5Y68.35% ROE-356.46% 52W High28.60 -82.83% Perf Year-30.65%
Cash/sh1.46 P/FCF- EPS past 3/5Y20.08% 27.29% ROIC- 52W Low4.20 16.90% Perf 3Y-79.39%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility12.17% 8.59% Perf 5Y-94.20%
Dividend TTM- EV/Sales- EPS Y/Y TTM4.49% Oper. Margin- ATR (14)0.93 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.39 Sales Y/Y TTM- Profit Margin- RSI (14)30.55 Recom3.00
Dividend Gr. 3/5Y- - Current Ratio0.39 EPS Q/Q-24.09% SMA20-30.27% Beta1.47 Target Price18.00
Payout- Debt/Eq- Sales Q/Q- SMA50-54.72% Rel Volume0.07 Prev Close5.46
Employees6 LT Debt/Eq- EarningsAug 13 BMO SMA200-35.95% Avg Volume697.40K Price4.91
IPONov 14, 2017 Option/ShortNo / Yes EPS/Sales Surpr.-33.89% - Trades Volume51,504 Change-10.07%
Date Action Analyst Rating Change Price Target Change
Jul-08-25Upgrade D. Boral Capital Hold → Buy $20
Feb-12-21Initiated Ladenburg Thalmann Buy $7
Sep-10-25 08:30AM
Sep-08-25 09:49AM
Sep-05-25 04:05PM
Sep-04-25 08:37AM
Sep-03-25 04:35PM
11:33AM Loading…
11:33AM
08:45AM
Aug-25-25 07:55AM
Aug-13-25 08:00AM
Aug-11-25 09:15AM
Aug-04-25 07:30AM
Aug-01-25 07:45AM
Jul-09-25 07:50AM
07:20AM
Jul-07-25 07:45AM
07:45AM Loading…
Jun-30-25 07:45AM
Jun-26-25 08:00AM
Jun-11-25 08:30AM
Jun-05-25 09:00AM
Jun-02-25 09:00AM
May-13-25 08:00AM
Apr-28-25 08:45AM
Apr-10-25 05:43AM
Mar-31-25 08:30AM
Mar-28-25 03:39AM
Mar-03-25 08:00AM
Feb-14-25 09:00AM
Feb-11-25 09:00AM
Jan-13-25 09:00AM
Dec-10-24 09:43AM
09:15AM Loading…
Dec-09-24 09:15AM
Nov-18-24 08:30AM
Nov-13-24 08:30AM
Nov-12-24 08:00AM
Nov-05-24 08:30AM
Oct-09-24 09:00AM
Sep-04-24 09:00AM
Aug-13-24 08:00AM
Jul-15-24 08:30AM
Jul-03-24 09:00AM
Jul-02-24 09:00AM
Jul-01-24 09:00AM
Jun-04-24 08:30AM
May-29-24 08:30AM
May-13-24 01:53PM
08:00AM
May-10-24 09:00AM
Apr-23-24 08:30AM
Apr-22-24 08:30AM
Mar-25-24 01:53PM
08:00AM
Mar-12-24 09:15AM
Feb-15-24 09:00AM
Jan-23-24 08:30AM
Jan-08-24 08:30AM
Dec-05-23 08:30AM
Nov-30-23 09:00AM
Nov-13-23 08:00AM
Nov-09-23 09:00AM
Nov-02-23 08:30AM
Oct-04-23 08:30AM
Sep-13-23 08:30AM
Sep-07-23 08:00AM
Sep-06-23 09:00AM
Sep-05-23 09:00AM
Aug-10-23 08:00AM
Jul-19-23 09:00AM
Jul-10-23 08:30AM
Jun-28-23 08:30AM
Jun-27-23 08:30AM
Jun-26-23 08:30AM
Jun-07-23 08:30AM
May-11-23 08:00AM
Apr-25-23 08:30AM
Mar-31-23 08:00AM
Feb-15-23 08:30AM
Feb-02-23 09:00AM
Jan-26-23 08:30AM
Nov-08-22 08:00AM
Oct-18-22 08:30AM
Sep-22-22 09:00AM
Sep-07-22 08:30AM
Aug-16-22 09:00AM
Aug-09-22 08:10AM
Jul-19-22 09:07AM
Jun-27-22 08:30AM
Jun-24-22 08:30AM
Jun-01-22 08:30AM
May-16-22 01:20PM
08:55AM
May-13-22 08:30AM
May-12-22 08:30AM
Apr-26-22 07:33AM
Apr-25-22 07:30AM
Apr-13-22 08:30AM
Mar-28-22 09:25AM
Mar-22-22 09:00AM
Mar-21-22 08:30AM
Mar-02-22 08:30AM
Jan-12-22 08:30AM
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.